Aug 1, 2000Dianolyn Capsules Recalled
notice issued by FDA of 'completed recall'...
CA (SafetyAlerts) - The Food and
Drug Administration (FDA) today reported that Diabetic Capital (U.S.) LLC is conducting a
recall of Dianolyn Capsules because the product fails to declare prescription drug
Dianolyn(tm) Capsules, OTC oral dietary supplement, in bottles of 30.
Recall #D-439-0. Class I
Lot #0914 EXP 10/02.
Phyytos Nutri-Pharma, Corona, California. (contract manufacturer).
Diabetic Capital (U.S.) LLC, Alhambra, California (responsible firm), by telephone on
March 16, 2000, by press release on March 22, 2000, and by letter on March 24, 2000.
Firm-initiated recall complete. This is the first public notice issued by the FDA.
California, Florida, Georgia, Kansas, Louisiana, Maryland, Missouri, Oregon, Pennsylvania,
Texas, Virginia and the District of Columbia.
10,788 boxes were distributed.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Notice of this product warning was sent via email
to SafeMail subscribers August 1,
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.